Loading...
Chemical structure of Evatanepag

GC19147

Evatanepag

Also known as 2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid

Evatanepag (CP-533536) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0·3 nM

ChemicalCAS223488-57-1MW468.57FormulaC25H28N2O5S
CAS number
223488-57-1
Molecular weight
468.57
Formula
C25H28N2O5S
Solubility
DMSO ： ≥ 32 mg/mL (68·29 mM)
InChIKey
WOHRHWDYFNWPNG-UHFFFAOYSA-N
Catalogue number
GC19147
Brand
GLPBIO
Computed properties PubChem CID 9890801 · XLogP 4.2 · TPSA 105 Ų · H-bond donors 1
XLogP
4.2
TPSA
105 Ų
H-bond donors
1
H-bond acceptors
7
Rotatable bonds
10
Heavy atoms
33

SMILES CC(C)(C)C1=CC=C(C=C1)CN(CC2=CC(=CC=C2)OCC(=O)O)S(=O)(=O)C3=CN=CC=C3

Computed descriptors from PubChem (CID 9890801), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.